Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts
Anticancer Research · 2025
DOI: 10.21873/anticanres.17600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yohei Asano und 15 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Ivermectin, Carbon-Sulfur Lyases, Fibroblasts, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc., San Diego, CA, U.S.A.
- Department of Surgery, University of California, San Diego, CA, U.S.A.
- Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
- AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Asano, Y., Han, Q., Li, S., Mizuta, K., Kang, B. M., Kim, J. S., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Morinaga, S., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2025). Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts. Anticancer Research. https://doi.org/10.21873/anticanres.17600
Vancouver
Asano Y, Han Q, Li S, Mizuta K, Kang BM, Kim JS, et al. Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts. Anticancer Research. 2025. doi:10.21873/anticanres.17600
BibTeX
@article{Asano2025,
author = {Asano, Yohei and Han, Qinghong and Li, Shukuan and Mizuta, Kohei and Kang, Byung Mo and Kim, Jin Soo and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Morinaga, Sei and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
title = {Selective Synergy of Ivermectin Combined With Recombinant Methioninase Against Colon-Cancer Cells in Contrast to Normal Fibroblasts},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17600}
}
EUVIMED